Efficacy of Highly Selective-a-1A-Adrenoceptor Antagonist Silodosin in Expulsive Therapy of Lower Ureteral Stones: A Randomized Controlled Study
Efficacy of highly selective-a-1A-adrenoceptor antagonist in expulsive therapy of lower ureteral stones
Chung Jing Wang
45 participants
Oct 1, 2010
Interventional
Conditions
Summary
a comparative study to evaluate the clinical role of highly selective a-1A blocker in the medical expulsive therapy of symptomatic lower ureteral stones.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
orally highly selective a-1A blocker(silodosin 4 mg and tamsulosin 0.2 mg) once daily for 2 weeks
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000571976